알레르기 주사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)
Allergy Shots Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
상품코드:1547106
리서치사:Persistence Market Research
발행일:2024년 08월
페이지 정보:영문 309 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
Persistence Market Research는 최근 알레르기 주사 세계 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 인사이트를 제공합니다.
주요 인사이트
알레르기 주사 시장 규모(2024년) : 28억 7,590만 달러
예상 시장 규모(2033년) : 64억 7,270만 달러
세계 시장 성장률(2024-2033년 CAGR) : 9.4%
알레르기 주사 시장 - 조사 범위
알레르기 면역요법이라고도 알려진 알레르기 주사는 특정 알레르겐에 대한 면역 체계를 점진적으로 감작시켜 알레르기 반응을 치료하는 데 사용됩니다. 이 주사는 수개월에서 수년까지 투여되며 꽃가루, 진드기, 곰팡이, 애완동물의 비듬과 같은 물질에 대한 알레르기를 관리하는 데 사용됩니다. 이 시장은 병원, 클리닉, 알레르기 전문 센터 및 재택 치료 현장을 위해 다양한 치료 요법과 제형을 제공하고 있습니다.
시장 성장의 원동력은 알레르기 질환의 유병률 증가, 의료비 지출 증가, 면역요법 기술의 발전으로 인한 치료 효과와 환자 결과 개선입니다.
시장 성장 촉진요인:
세계 알레르기 주사 시장은 알레르기 질환의 유병률 증가와 효과적인 치료 옵션으로서 알레르겐 면역요법에 대한 인식이 높아지는 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 알레르기성 비염, 천식 및 기타 알레르기 질환의 유병률 증가가 시장 확대에 기여하고 있습니다. 또한, 보다 효과적이고 개별화된 알레르겐 추출물의 개발 및 투여 기술 향상과 같은 기술적 진보도 시장 성장의 원동력이 되고 있습니다. 또한, 장기적인 해결책을 찾는 환자들 사이에서 알레르기 주사의 채택이 증가하고 있으며, 증상 치료제에 대한 의존도가 감소하고 있는 것도 시장 수요를 더욱 촉진하고 있습니다.
시장 억제요인:
알레르기 주사 시장은 유망한 성장 전망에도 불구하고 치료 기간, 비용, 환자 순응도 등의 문제에 직면해 있습니다. 일부 환자들은 긴 치료 기간과 잦은 의료기관 방문으로 인해 알레르기 주사를 기피하는 경향이 있습니다. 높은 치료 비용과 알레르겐 면역요법에 대한 제한된 보험 적용은 특히 의료 예산이 제한된 신흥국에서 시장 침투에 영향을 미칠 수 있습니다. 이러한 장벽을 극복하기 위해서는 환자 교육 강화, 저렴한 치료 옵션에 대한 접근성 개선, 알레르겐 면역요법에 대한 보험 적용 확대가 필요합니다.
시장 기회:
알레르기 주사 시장은 기술 혁신, 인구 동향, 의료 서비스 제공 모델의 진화로 인해 큰 성장 기회를 맞이하고 있습니다. 알레르기 검사 및 진단 도구의 발전으로 환자 식별 및 치료 맞춤화가 개선되고 있습니다. 또한, 모바일 건강 애플리케이션 및 원격의료 플랫폼과 같은 디지털 건강 기술의 통합은 환자의 알레르기 치료에 대한 접근성과 치료 순응도를 향상시키고 있습니다. 식품 알레르기 및 만성 부비동염에 대한 적용 가능성 등 알레르겐 면역 치료의 적응증 확대는 시장 범위를 넓히고 기술 혁신을 촉진하고 있습니다.
본 보고서에서 다루는 주요 질문들
알레르기 주사 시장의 세계 성장을 촉진하는 주요 요인은 무엇인가?
알레르기 면역 치료 기술의 발전은 시장 역학에 어떤 영향을 미쳤습니까?
알레르기 주사 시장이 직면한 주요 과제는 무엇이며 어떻게 대처할 수 있는가?
알레르기 주사 시장의 주요 기업은 어디에 있으며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계 알레르기 주사 시장의 새로운 트렌드와 향후 전망은?
목차
제1장 주요 요약
제2장 시장 개요
시장 범위/분류
시장 정의/범위/제한
포함 사항·제외 사항
제3장 주요 시장 동향
시장에 영향을 미치는 주요 동향
제품 혁신/개발 동향
제4장 주요 성공요인
제품 채용/사용 상황 분석
제품 USP/특징
파이프라인 평가
최근의 제품 승인과 발매
PESTLE 분석
Porters 분석
규제 시나리오
밸류체인 분석
제5장 시장 배경
거시경제 요인
예측요인 - 관련성과 영향
역학
제6장 COVID-19 위기 - 영향 평가
COVID-19와 영향 분석
제품별
면역요법별
적응증
알레르겐별
유통 채널별
지역별
2024년 시장 시나리오
제7장 세계 시장 수량(단위) 분석
과거 수량(단위) 분석, 2019-2023년
현재 및 향후 수량(단위) 예측, 2024-2033년
전년비 성장 동향 분석
제8장 세계 시장 - 가격 분석
지역별 가격 분석 : 제품별
가격 내역
제조업체 레벨 가격 설정
유통업체 레벨 가격 설정
세계 평균 가격 분석 벤치마크
가격 설정 가정
제9장 세계 시장 수요(금액 또는 규모, 백만 달러) 분석
과거 시장 금액(백만 달러) 분석, 2019-2023년
현재 및 향후 시장 금액(백만 달러) 예측, 2024-2033년
전년비 성장 동향 분석
절대액 기회 분석
제10장 세계 시장 분석, 제품별
소개/주요 조사 결과
과거 시장 규모(백만 달러)와 수량(단위) 분석, 제품별, 2019-2023년
현재 및 향후 시장 규모(백만 달러)와 수량(단위) 분석과 예측, 제품별, 2024-2033년
SLIT 태블릿
경구
주사
기타
시장 매력 분석 : 제품별
제11장 세계 시장 분석, 면역요법별
소개/주요 조사 결과
과거 시장 규모(백만 달러) 분석, 면역요법별, 2019-2023년
현재 및 향후 시장 규모(백만 달러) 분석과 예측, 면역요법별, 2024-2033년
설하 면역요법(SLIT)
피하 면역요법(SCIT)
기타
시장 매력 분석 : 면역요법별
제12장 세계 시장 분석, 적응증별
소개/주요 조사 결과
과거 시장 규모(백만 달러) 분석, 적응증별, 2019-2023년
현재 및 향후 시장 규모(백만 달러) 분석과 예측, 적응증별, 2024-2033년
알레르기 비염
알레르기성 천식
식품 알레르기
아토피 피부염
기타
시장 매력 분석 : 적응증별
제13장 세계 시장 분석, 알레르겐별
소개/주요 조사 결과
과거 시장 규모(백만 달러) 분석, 알레르겐별, 2019-2023년
현재 및 향후 시장 규모(백만 달러) 분석과 예측, 알레르겐별, 2024-2033년
화분
집먼지진드기(HDM)
형
동물 늙어
봉독
바퀴벌레/곤충
기타
시장 매력 분석 : 알레르겐별
제14장 세계 시장 분석, 유통 채널별
소개/주요 조사 결과
과거 시장 규모(백만 달러) 분석, 유통 채널별, 2019-2023년
현재 및 향후 시장 규모(백만 달러) 분석과 예측, 유통 채널별, 2024-2033년
기관투자가용 판매
소매 판매
시장 매력 분석 : 유통 채널별
제15장 세계 시장 분석 : 지역별
소개
과거 시장 규모(백만 달러) 분석, 지역별, 2019-2023년
현재 및 향후 시장 규모(백만 달러) 분석과 예측, 지역별, 2024-2033년
북미
라틴아메리카
유럽
남아시아
동아시아
오세아니아
중동 및 아프리카(MEA)
시장 매력 분석 : 지역별
제16장 북미 시장 분석
제17장 라틴아메리카 시장 분석
제18장 유럽 시장 분석
제19장 남아시아 시장 분석
제20장 동아시아 시장 분석
제21장 오세아니아 시장 분석
제22장 중동 및 아프리카 시장 분석
제23장 시장 구조 분석
시장 분석 : 기업 계층별
주요 기업의 시장 점유율 분석
시장 입지 분석
제24장 경쟁 분석
경쟁 대시보드
브랜딩과 프로모션 전략
주요 개발 분석
경쟁 상세 정보
ALK Abello
Stallergenes Greer
Allergy Therapeutics
Aimmune Therapeutics
Anergis
Arrayit Corporation
Biomay AG
HAL Allergy Group
DBV Technologies
제25장 사용되는 가정과 두문자어
제26장 조사 방법
ksm
영문 목차
영문목차
Persistence Market Research has recently released a comprehensive report on the worldwide market for allergy shots. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
Allergy Shots Market Size (2024E): USD 2,875.9 million
Projected Market Value (2033F): USD 6,472.7 million
Global Market Growth Rate (CAGR 2024 to 2033): 9.4%
Allergy Shots Market - Report Scope:
Allergy shots, also known as allergen immunotherapy, are used to treat allergic reactions by gradually desensitizing the immune system to specific allergens. These shots are administered over a period of months or years and are used to manage allergies to substances such as pollen, dust mites, mold, and pet dander. The market caters to hospitals, clinics, specialized allergy centers, and homecare settings, offering various treatment regimens and formulations.
Market growth is driven by an increasing prevalence of allergic disorders, rising healthcare expenditures, and advancements in immunotherapy techniques, enhancing treatment efficacy and patient outcomes.
Market Growth Drivers:
The global allergy shots market is propelled by several key factors, including the growing incidence of allergic diseases and an increasing awareness of allergen immunotherapy as an effective treatment option. The rising prevalence of allergic rhinitis, asthma, and other allergic conditions is contributing to market expansion. Technological advancements, such as the development of more effective and personalized allergen extracts and improvements in administration techniques, are also driving market growth. Additionally, the growing adoption of allergy shots among patients seeking long-term solutions and reduced dependency on symptomatic medications further fuels market demand.
Market Restraints:
Despite promising growth prospects, the allergy shots market faces challenges related to treatment duration, cost, and patient compliance. The lengthy treatment duration and the need for frequent visits to healthcare providers can deter some patients from pursuing allergy shots. High treatment costs and limited insurance coverage for allergen immunotherapy may also impact market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these barriers requires enhanced patient education, improved access to affordable treatment options, and greater insurance coverage for allergen immunotherapy.
Market Opportunities:
The allergy shots market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. Advances in allergy testing and diagnostic tools are improving patient identification and treatment customization. Additionally, the integration of digital health technologies, such as mobile health applications and telemedicine platforms, enhances patient access to allergy care and treatment adherence. Expanding indications for allergen immunotherapy, including potential applications for food allergies and chronic sinusitis, broadens the market scope and stimulates innovation.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the allergy shots market globally?
How are advancements in allergen immunotherapy techniques influencing market dynamics?
What are the key challenges faced by the allergy shots market, and how can they be addressed?
Who are the leading players in the allergy shots market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global allergy shots market?
Competitive Intelligence and Business Strategy:
Leading players in the global allergy shots market, including companies such as Allergy Therapeutics, Stallergenes Greer, and HAL Allergy, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced allergen extracts and delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical research institutions, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education is essential to drive market growth and enhance patient outcomes in the evolving allergy shots landscape.
Key Companies Profiled:
Allergy Therapeutics
Stallergenes Greer
HAL Allergy
Merck & Co., Inc.
Novartis AG
Antigen Laboratories
ALK-Abello A/S
DBV Technologies
Schering-Plough Corporation
Mylan N.V.
Key Segments Covered in Allergy Shots Industry Research
Product:
SLIT Tablets
Oral
Injections
Immunotherapy:
Sublingual Immunotherapy (SLIT)
Subcutaneous Immunotherapy (SCIT)
Specific Immunotherapy
Indication:
Allergic Rhinitis
Allergic Asthma
Food Allergy
Atopic Dermatitis
Allergen:
Pollens
House Dust Mites (HDM)
Mold
Animal Dander
Bee Venom
Cockroaches/Insects
Distribution Channel:
Institutional Sales
Retail Sales
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Pipeline Assessment
4.4. Recent Product Approval and Launches
4.5. PESTLE Analysis
4.6. Porter's Analysis
4.7. Regulatory Scenario
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Allergy Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growth of the Top Companies
5.2.2. Rising Prevalence of Various Types of Allergies
5.2.3. Cost of Products
5.2.4. Product and Stock Availability
5.2.5. Mergers and Acquisitions
5.2.6. Changing Lifestyle
5.2.7. Strong Product Pipeline
5.2.8. Growing Corporate Agreements
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Immunotherapy
6.1.3. BY Indication
6.1.4. By Allergen
6.1.5. By Distribution Channel
6.1.6. By Region
6.2. 2024 Market Scenario
7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Volume (in Units) Analysis, 2019-2023
7.2. Current and Future Volume (in Units) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
10.3.1. SLIT Tablets
10.3.1.1. Odactra
10.3.1.2. Grastek
10.3.1.3. Ragwitek
10.3.1.4. Oralair
10.3.1.5. Actair
10.3.1.6. Others
10.3.2. Oral
10.3.2.1. Palforzia
10.3.2.2. Others
10.3.3. Injections
10.3.4. Others
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Immunotherapy
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Immunotherapy, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Immunotherapy, 2024-2033
11.3.1. Sublingual Immunotherapy (SLIT)
11.3.2. Subcutaneous Immunotherapy (SCIT)
11.3.2.1. Specific Immunotherapy
11.3.3. Others
11.4. Market Attractiveness Analysis By Immunotherapy
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
12.3.1. Allergic Rhinitis
12.3.2. Allergic Asthma
12.3.3. Food Allergy
12.3.4. Atopic Dermatitis
12.3.5. Others
12.4. Market Attractiveness Analysis By Indication
13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Allergen
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Allergen, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergen, 2024-2033
13.3.1. Pollens
13.3.1.1. Grass Pollens
13.3.1.2. Weed Pollens
13.3.1.3. Tree Pollens
13.3.2. House Dust Mites (HDM)
13.3.3. Mould
13.3.4. Animal Dander
13.3.5. Bee Venom
13.3.6. Cockroaches/Insects
13.3.7. Others
13.4. Market Attractiveness Analysis By Allergen
14. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Distribution Channel
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2033
14.3.1. Institutional Sales
14.3.1.1. Government Hospitals
14.3.1.2. Semi-Government Hospitals
14.3.1.3. Private Hospitals
14.3.2. Retail Sales
14.3.2.1. Retail Pharmacy
14.3.2.2. Drug Stores
14.3.2.3. Online Pharmacy
14.4. Market Attractiveness Analysis By Distribution Channel
15. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. South Asia
15.3.5. East Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. North America Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Product
16.3.3. By Immunotherapy
16.3.4. By Indication
16.3.5. By Allergen
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Immunotherapy
16.4.4. By Indication
16.4.5. By Allergen
16.4.6. By Distribution Channel
16.5. Country Level Analysis & Forecast
16.5.1. U.S. Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Immunotherapy
16.5.1.2.3. By Indication
16.5.1.2.4. By Allergen
16.5.1.2.5. By Distribution Channel
16.5.2. Canada Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Immunotherapy
16.5.2.2.3. By Indication
16.5.2.2.4. By Allergen
16.5.2.2.5. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Product
17.3.3. By Immunotherapy
17.3.4. By Indication
17.3.5. By Allergen
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Immunotherapy
17.4.4. By Indication
17.4.5. By Allergen
17.4.6. By Distribution Channel
17.5. Country Level Analysis & Forecast
17.5.1. Brazil Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Immunotherapy
17.5.1.2.3. By Indication
17.5.1.2.4. By Allergen
17.5.1.2.5. By Distribution Channel
17.5.2. Mexico Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Immunotherapy
17.5.2.2.3. By Indication
17.5.2.2.4. By Allergen
17.5.2.2.5. By Distribution Channel
17.5.3. Argentina Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Immunotherapy
17.5.3.2.3. By Indication
17.5.3.2.4. By Allergen
17.5.3.2.5. By Distribution Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Europe Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. France
18.3.1.3. Italy
18.3.1.4. U.K.
18.3.1.5. Spain
18.3.1.6. Russia
18.3.1.7. BENELUX
18.3.1.8. Rest of Europe
18.3.2. By Product
18.3.3. By Immunotherapy
18.3.4. By Indication
18.3.5. By Allergen
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Immunotherapy
18.4.4. By Indication
18.4.5. By Allergen
18.4.6. By Distribution Channel
18.5. Country Level Analysis & Forecast
18.5.1. Germany Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Immunotherapy
18.5.1.2.3. By Indication
18.5.1.2.4. By Allergen
18.5.1.2.5. By Distribution Channel
18.5.2. France Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Immunotherapy
18.5.2.2.3. By Indication
18.5.2.2.4. By Allergen
18.5.2.2.5. By Distribution Channel
18.5.3. Italy Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Immunotherapy
18.5.3.2.3. By Indication
18.5.3.2.4. By Allergen
18.5.3.2.5. By Distribution Channel
18.5.4. U.K. Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Product
18.5.4.2.2. By Immunotherapy
18.5.4.2.3. By Indication
18.5.4.2.4. By Allergen
18.5.4.2.5. By Distribution Channel
18.5.5. Spain Market Analysis
18.5.5.1. Introduction
18.5.5.2. Market Analysis and Forecast by Market Taxonomy
18.5.5.2.1. By Product
18.5.5.2.2. By Immunotherapy
18.5.5.2.3. By Indication
18.5.5.2.4. By Allergen
18.5.5.2.5. By Distribution Channel
18.5.6. Russia Market Analysis
18.5.6.1. Introduction
18.5.6.2. Market Analysis and Forecast by Market Taxonomy
18.5.6.2.1. By Product
18.5.6.2.2. By Immunotherapy
18.5.6.2.3. By Indication
18.5.6.2.4. By Allergen
18.5.6.2.5. By Distribution Channel
18.5.7. BENELUX Market Analysis
18.5.7.1. Introduction
18.5.7.2. Market Analysis and Forecast by Market Taxonomy
18.5.7.2.1. By Product
18.5.7.2.2. By Immunotherapy
18.5.7.2.3. By Indication
18.5.7.2.4. By Allergen
18.5.7.2.5. By Distribution Channel
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Thailand
19.3.1.3. Indonesia
19.3.1.4. Malaysia
19.3.1.5. Rest of South Asia
19.3.2. By Product
19.3.3. By Immunotherapy
19.3.4. By Indication
19.3.5. By Allergen
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Immunotherapy
19.4.4. By Indication
19.4.5. By Allergen
19.4.6. By Distribution Channel
19.5. Country Level Analysis & Forecast
19.5.1. India Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Immunotherapy
19.5.1.2.3. By Indication
19.5.1.2.4. By Allergen
19.5.1.2.5. By Distribution Channel
19.5.2. Thailand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Immunotherapy
19.5.2.2.3. By Indication
19.5.2.2.4. By Distribution Channel
19.5.3. Indonesia Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Product
19.5.3.2.2. By Immunotherapy
19.5.3.2.3. By Indication
19.5.3.2.4. By Allergen
19.5.3.2.5. By Distribution Channel
19.5.4. Malaysia Market Analysis
19.5.4.1. Introduction
19.5.4.2. Market Analysis and Forecast by Market Taxonomy
19.5.4.2.1. By Product
19.5.4.2.2. By Immunotherapy
19.5.4.2.3. By Indication
19.5.4.2.4. By Allergen
19.5.4.2.5. By Distribution Channel
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
20.3.1. By Country
20.3.1.1. China
20.3.1.2. Japan
20.3.1.3. South Korea
20.3.2. By Product
20.3.3. By Immunotherapy
20.3.4. By Indication
20.3.5. By Allergen
20.3.6. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Immunotherapy
20.4.4. By Indication
20.4.5. By Allergen
20.4.6. By Distribution Channel
20.5. Country Level Analysis & Forecast
20.5.1. China Market Analysis
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Immunotherapy
20.5.1.2.3. By Indication
20.5.1.2.4. By Allergen
20.5.1.2.5. By Distribution Channel
20.5.2. Japan Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Immunotherapy
20.5.2.2.3. By Indication
20.5.2.2.4. By Allergen
20.5.2.2.5. By Distribution Channel
20.5.3. South Korea Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Immunotherapy
20.5.3.2.3. By Indication
20.5.3.2.4. By Allergen
20.5.3.2.5. By Distribution Channel
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
21.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Product
21.3.3. By Immunotherapy
21.3.4. By Indication
21.3.5. By Allergen
21.3.6. By Distribution Channel
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Immunotherapy
21.4.4. By Indication
21.4.5. By Allergen
21.4.6. By Distribution Channel
21.5. Country Level Analysis & Forecast
21.5.1. Australia Market Analysis
21.5.1.1. Introduction
21.5.1.2. Market Analysis and Forecast by Market Taxonomy
21.5.1.2.1. By Product
21.5.1.2.2. By Immunotherapy
21.5.1.2.3. By Indication
21.5.1.2.4. By Allergen
21.5.1.2.5. By Distribution Channel
21.5.2. New Zealand Market Analysis
21.5.2.1. Introduction
21.5.2.2. Market Analysis and Forecast by Market Taxonomy
21.5.2.2.1. By Product
21.5.2.2.2. By Immunotherapy
21.5.2.2.3. By Indication
21.5.2.2.4. By Allergen
21.5.2.2.5. By Distribution Channel
21.6. Market Trends
21.7. Key Market Participants - Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
22. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
22.1. Introduction
22.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
22.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Turkiye
22.3.1.3. Northern Africa
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Product
22.3.3. By Immunotherapy
22.3.4. By Indication
22.3.5. By Allergen
22.3.6. By Distribution Channel
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By Immunotherapy
22.4.4. By Indication
22.4.5. By Allergen
22.4.6. By Distribution Channel
22.5. Country Level Analysis & Forecast
22.5.1. GCC Countries Market Analysis
22.5.1.1. Introduction
22.5.1.2. Market Analysis and Forecast by Market Taxonomy
22.5.1.2.1. By Product
22.5.1.2.2. By Immunotherapy
22.5.1.2.3. By Indication
22.5.1.2.4. By Allergen
22.5.1.2.5. By Distribution Channel
22.5.2. Turkiye Market Analysis
22.5.2.1. Introduction
22.5.2.2. Market Analysis and Forecast by Market Taxonomy
22.5.2.2.1. By Product
22.5.2.2.2. By Immunotherapy
22.5.2.2.3. By Indication
22.5.2.2.4. By Allergen
22.5.2.2.5. By Distribution Channel
22.5.3. Northern Africa Market Analysis
22.5.3.1. Introduction
22.5.3.2. Market Analysis and Forecast by Market Taxonomy
22.5.3.2.1. By Product
22.5.3.2.2. By Immunotherapy
22.5.3.2.3. By Indication
22.5.3.2.4. By Allergen
22.5.3.2.5. By Distribution Channel
22.5.4. South Africa Market Analysis
22.5.4.1. Introduction
22.5.4.2. Market Analysis and Forecast by Market Taxonomy
